LOGIN
Intravenous Unit-Dose Tranexamic Acid for Blood Loss Management in Posterior Lumbar Interbody Fusion
May 2023
Intravenous Unit-Dose Tranexamic Acid for Blood Loss Management in Posterior Lumbar Interbody Fusion
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
The effect of intravenous unit-dose tranexamic acid on visible and hidden blood loss in posterior lumbar interbody fusion: a randomized clinical trial.
Sci Rep. 2023 Mar 22;13(1): 4714.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
100 patients undergoing a posterior lumbar interbody fusion procedure were randomized to receive a unit dose of intravenous tranexamic acid 15 minutes before skin incision (n=50) or normal saline (n=50). The outcomes of interest included operative time, blood loss, drainage volume, transfusion rate, events, coagulation and inflammatory markers. Biomarkers were measured at 1 and 4 days post-operati...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.